M&A Deal Summary

Phagelux Acquires OmniLytics

On July 20, 2015, Phagelux acquired life science company OmniLytics

Acquisition Highlights
  • This is Phagelux’s 1st transaction in the Life Science sector.
  • This is Phagelux’s 1st transaction in the United States.
  • This is Phagelux’s 1st transaction in Utah.

M&A Deal Summary
Date 2015-07-20
Target OmniLytics
Sector Life Science
Buyer(s) Phagelux
Deal Type Add-on Acquisition

Target

OmniLytics

Sandy, Utah, United States
OmniLytics, Inc. is engaged in research and development of bacteriophage solutions for pathogen control in the fields of agriculture, food and water safety, and sanitation.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Phagelux

Shanghai, China
Category Company
Sector Life Science
DESCRIPTION

Phagelux, Inc. is a developer of anti-bacterial solutions across multiple fields utilizing various phage and phage-based technologies and solutions.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2015) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-14 Scithera Microbial Technologies - Intellectual Property for Multiple Lysins

China

Scithera Microbial Technologies - Intellectual Property for Multiple Lysins is a provider of IT solutions to life science industry.

Buy -
Mergr

Product

Company

Legal